logo
Plus   Neg
Share
Email

Roche Enters Licensing Deal With Sarepta On Duchenne Muscular Dystrophy

Roche (RHHBY) said it obtains the exclusive right to launch and commercialize SRP-9001, Sarepta Therapeutics, Inc.'s (SRPT) investigational micro-dystrophin gene therapy for Duchenne muscular dystrophy or DMD outside the United States.

As per the terms of the agreement, Sarepta will receive an upfront payment of $750 million in cash and $400 million in equity.

In addition, Sarepta is eligible to receive up to $1.7 billion in regulatory and sales milestones, plus royalties on net sales.

Roche and Sarepta will equally share global development expenses.

As part of the agreement, Roche also obtains an option to acquire ex-U.S. rights to certain future DMD-specific programs from Sarepta, in exchange for separate milestone and royalty considerations, and cost sharing.

The companies anticipate that the agreement will close in the first quarter of 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Safavieh LLC recalled about 760 units of Aura and Silas 3-Drawer Chests for possible serious tip-over and entrapment hazards that can result in death or injuries to children, the U.S. Consumer Product Safety Commission said in a statement. The company said the chests are unstable if they are not anchored to the wall. Shares of Standard Chartered Plc were losing around 4 percent in London trading after the bank warned on fiscal 2020 income growth mainly due to coronavirus impact. This was despite reporting a profit before tax in its fourth quarter, compared to last year's loss. For 2020, the company now expects income growth to be below its medium-term target range of 5 percent to 7 percent. A 2018 fatal crash involving a Tesla Inc. vehicle was likely caused by the car's autopilot system as well as distracted driving, according to a report by the National Transportation Safety Board or NTSB. The driver of the Tesla's Model X electric-powered sport utility vehicle, Walter Huang, was killed when it collided with a damaged crash attenuator on March 23, 2018 in Mountain View, California.
Follow RTT
>